Lisata Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Lisata Therapeutics has a total shareholder equity of $47.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $54.7M and $6.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$50.54m |
| Equity | US$47.89m |
| Total liabilities | US$6.80m |
| Total assets | US$54.69m |
Recent financial health updates
Is Lisata Therapeutics (NASDAQ:LSTA) In A Good Position To Deliver On Growth Plans?
Mar 22
We Think Caladrius Biosciences (NASDAQ:CLBS) Needs To Drive Business Growth Carefully
Sep 15We Think Caladrius Biosciences (NASDAQ:CLBS) Needs To Drive Business Growth Carefully
May 02We're Keeping An Eye On Caladrius Biosciences' (NASDAQ:CLBS) Cash Burn Rate
Jan 05Companies Like Caladrius Biosciences (NASDAQ:CLBS) Are In A Position To Invest In Growth
May 09Recent updates
Is Lisata Therapeutics (NASDAQ:LSTA) In A Good Position To Deliver On Growth Plans?
Mar 22We Think Caladrius Biosciences (NASDAQ:CLBS) Needs To Drive Business Growth Carefully
Sep 15Caladrius rallies on approval of merger, name change to Lisata Therapeutics
Sep 14Caladrius Biosciences GAAP EPS of -$0.11 beats by $0.01
Aug 04We Think Caladrius Biosciences (NASDAQ:CLBS) Needs To Drive Business Growth Carefully
May 02We're Keeping An Eye On Caladrius Biosciences' (NASDAQ:CLBS) Cash Burn Rate
Jan 05Companies Like Caladrius Biosciences (NASDAQ:CLBS) Are In A Position To Invest In Growth
May 09Caladrius suspends CLBS119 COVID-19 study
Dec 14Here's Why We're Not Too Worried About Caladrius Biosciences' (NASDAQ:CLBS) Cash Burn Situation
Nov 30
Financial Position Analysis
Short Term Liabilities: LSTA's short term assets ($53.9M) exceed its short term liabilities ($6.6M).
Long Term Liabilities: LSTA's short term assets ($53.9M) exceed its long term liabilities ($210.0K).
Debt to Equity History and Analysis
Debt Level: LSTA is debt free.
Reducing Debt: LSTA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LSTA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LSTA has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 2.9% each year.